Atria Investments’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.14M Buy
17,518
+671
+4% +$49.8K 0.01% 984
2025
Q4
$1.33M Sell
16,847
-662
-4% -$50.7K 0.02% 915
2025
Q3
$1.28M Buy
17,509
+2,876
+20% +$211K 0.01% 927
2025
Q2
$1.11M Buy
14,633
+3,232
+28% +$229K 0.01% 977
2025
Q1
$867K Sell
11,401
-956
-8% -$71.2K 0.01% 1062
2024
Q4
$816K Buy
12,357
+658
+6% +$46.1K 0.01% 1090
2024
Q3
$816K Buy
11,699
+5,644
+93% +$339K 0.01% 1084
2024
Q2
$320K Buy
+6,055
New +$368K ﹤0.01% 1551

Other funds holding SOLV

Atria Investments's SOLV Position: Q1 2026 in Review

Atria Investments increased its Solventum (SOLV) stake by 4% in Q1 2026, buying an estimated $49.8K and bringing the position to 17,518 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #984.

Atria Investments first reported a position in SOLV in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.33M in Q4 2025. 877 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Atria Investments held 17,518 shares of Solventum worth $1.14M as of Q1 2026.
  • Atria Investments bought 671 Solventum shares in Q1 2026, an estimated $49.8K.
  • Solventum made up 0.01% of Atria Investments's portfolio in Q1 2026, its #984 holding.
  • Atria Investments first reported a position in Solventum in Q2 2024 and has held it in 8 quarters since.
  • Atria Investments's Solventum position peaked at $1.33M in Q4 2025.
  • 877 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.